Strand V, Kaeley GS, Bergman MJ, Gladman DD, Coates LC, Sherif B, Hur P, Parikh B, Gilloteau I, Mease PJ. The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomized phase 3 trial. Lancet Rheumatol. 2022 Mar 1;4(3):e208-19.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Sehinovych I, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the 2020 Virtual American Academy of Neurology Annual Meeting (Conference cancelled); April 25, 2020. Toronto, Canada. [abstract] Neurology. 2020 Apr 14; 94(15 Supplement):4442.
Mines D, Gu Y, Novelli L, Lui Q, Gelfand J. Risk of CNS demyelinating diseases among patients with psoriasis and rheumatoid arthritis. Poster presented at the 2007 59th Annual Meeting of the American Academy of Neurology; May 2007. Boston, MA. [abstract] Neurology. 2007; 68(12, Suppl 1):A165.